Tower Behavioral Health
-
Services:
- No formal relationship with prescribing entity
- Other contracted prescribing entity
- In-network prescribing entity
- State department of health
- State mental health department
- The Joint Commission
- Drug Enforcement Agency (DEA)
- Buprenorphine used in Treatment
- Naltrexone used in Treatment
- Brief intervention
- Substance use disorder counseling
- 12-step facilitation
- Breathalyzer or blood alcohol testing
- TB screening
- Testing for Hepatitis B (HBV)
- Metabolic syndrome monitoring
- STD testing
- HIV testing
- Drug or alcohol urine screening
- Testing for Hepatitis C (HCV)
- Accepts clients using medication assisted treatment for alcohol use disorder but prescribed elsewhere
- Vaping not permitted
- Female
- Male
- Family counseling
- HIV or AIDS education, counseling, or support
- Health education services other than HIV/AIDS or hepatitis
- Hepatitis education, counseling, or support
- Individual counseling
- Substance use disorder education
- Group counseling
- Smoking/vaping/tobacco cessation counseling
- Psychiatric hospital
- Sign language services for the deaf and hard of hearing
- Spanish
- Self-help groups
- Housing services
- Assistance with obtaining social services
- Mentoring/peer support
- Other contracted prescribing entity
- In-network prescribing entity
- No formal relationship with prescribing entity
- Young Adults
- Adults
- Private for-profit organization
- Mental health services
- Social skills development
- Domestic violence services, including family or partner
- Case management service
- Suicide prevention services
- Complete medical history/physical exam
- Screening for tobacco use
- Screening for substance use
- Screening for mental disorders
- Comprehensive mental health assessment
- Comprehensive substance use assessment
- Accepts clients using MAT but prescribed elsewhere
- Buprenorphine without naloxone
- Clonidine
- Acamprosate (Campral®)
- Disulfiram
- Buprenorphine (extended-release, injectable)
- Medication for mental disorders
- Nicotine replacement
- Naltrexone (oral)
- Naltrexone (extended-release, injectable)
- Buprenorphine with naloxone
- Hospital inpatient treatment
- Hospital inpatient/24-hour hospital inpatient
- Cash or self-payment
- State-financed health insurance plan other than Medicaid
- Federal, or any government funding for substance use treatment programs
- Private health insurance
- Medicaid
- SAMHSA funding/block grants
- Medicare
- Federal military insurance (e.g., TRICARE)
- Clients who have experienced trauma
- Members of military families
- Veterans
- Clients with HIV or AIDS
- Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)
- Clients with co-occurring mental and substance use disorders
- Seniors or older adults
- Active duty military
- Clients who have experienced intimate partner violence, domestic violence
- Adult men
- Clients who have experienced sexual abuse
- Adult women
- Treatment for co-occurring substance use plus either serious mental health illness in adults/serious emotional disturbance in children
- Substance use treatment
- Smoking not permitted
- Discharge Planning
- Aftercare/continuing care
- Outcome follow-up after discharge
- Naloxone and overdose education
External Source of Medications Used for Alcohol Use Disorder Treatment
License/Certification/Accreditation
Opioid Medications used in Treatment
Treatment Approaches
Testing
Type of Alcohol Use Disorder Treatment
Facility Vaping Policy
Gender Accepted
Education and Counseling Services
Hospitals
Language Services
Recovery Support Services
External Opioid Medications Source
Age Groups Accepted
Facility Operation (e.g., Private, Public)
Ancillary Services
Assessment/Pre-treatment
Type of Opioid Treatment
Pharmacotherapies
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Payment/Insurance/Funding Accepted
Special Programs/Groups Offered
Type of Care
Facility Smoking Policy
Transitional Services